Sun Pharma plans to fund the acquisition through a combination of available cash resources (USD 2-2.5 billion) and committed financing from banks (USD 9.25-9.75...
The purchase consideration includes a deferred consideration in the form of earnout, payable subject to achievement of certain performance metrics / conditions, the company...
